ArticleTherapeutic advances in medical oncology2022
First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for
Guangjian Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it